BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 7308505)

  • 1. Pituitary-ovarian function after tubal ligation.
    Alvarez-Sanchez F; Segal SJ; Brache V; Adejuwon CA; Leon P; Faundes A
    Fertil Steril; 1981 Nov; 36(5):606-9. PubMed ID: 7308505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization.
    Wu E; Xiao B; Yan W; Li H; Wu B
    Contraception; 1992 Jun; 45(6):583-93. PubMed ID: 1617967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips.
    Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S
    Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The menstrual cycle in women using an intrauterine device.
    Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
    Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on ovarian and adrenal steroids at different phases of the menstrual cycle. 1. Dynamic changes during the periovulatory period.
    Aedo AR; Landgren BM; Diczfalusy E
    Contraception; 1981 Feb; 23(2):107-24. PubMed ID: 7238039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
    Niaraki MA; Moghissi KS; Borin K
    Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menstrual patterns and progesterone circulating levels following different procedures of tubal occlusion.
    Rivera R; Gaitan JR; Ruiz R; Hurley DP; Arenas M; Flores C; Hernandez AB
    Contraception; 1989 Aug; 40(2):157-69. PubMed ID: 2758840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary, ovarian and endometrial effects of progesterone released prematurely during the proliferative phase.
    Shumin X; Johannisson E; Landgren BM; Diczfalusy E
    Contraception; 1983 Feb; 27(2):177-93. PubMed ID: 6851555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
    Segal SJ; Alvarez-Sanchez F; Adejuwon CA; Brache de Mejia V; Leon P; Faundes A
    Fertil Steril; 1985 Aug; 44(2):214-8. PubMed ID: 4018277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen deficiency after tubal ligation.
    Cattanach J
    Lancet; 1985 Apr; 1(8433):847-9. PubMed ID: 2858712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in physiological, EEG and psychological parameters in women during the spontaneous menstrual cycle and following oral contraceptives.
    Becker D; Creutzfeldt OD; Schwibbe M; Wuttke W
    Psychoneuroendocrinology; 1982; 7(1):75-90. PubMed ID: 7100370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to intermittent RU486 in women.
    Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
    Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.